Classification
- Anatomical main groupAAlimentary tract and metabolism
- Therapeutic subgroupA02
- Pharmacological subgroupA02B
- Chemical subgroupA02BA
- Chemical substanceA02BA02Ranitidine
Where it is registered
Each register and historical list with its number of registrations and a few of them.
Brazil
Anvisa · 138 registrations
- cloridrato de ranitidinaAché Laboratórios Farmacêuticos S.A
- Cloridrato de RanitidinaNewcom Farmaceutica Ltda.
- cloridrato de ranitidinaFundação Para O Remédio Popular - Furp
- Cloridrato de RanitidinaNativita Ind. Com. Ltda.
Canada
Health Canada · 96 registrations
At a glance
- ATC code
- A02BA02
- ATC group
- Alimentary tract and metabolism
- Registers
- 8
- Historical lists
- 3
- Registrations
- 356
- With their own page
- 60
- Companies
- 184
All medicines with Ranitidine
Human medicines from every register that match Ranitidine by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
368 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Ranitidine | Canada | 150 MG | Tablet | Not marketed | Sanis Health INC |
| Ranitidine | Canada | 300 MG | Tablet | Not marketed | Sanis Health INC |
| Ranitidine Hydrochloride | United States | 150MG BASE, 300MG BASE | capsule | Marketed | Novitium Pharma |
| Ranitidine Hydrochloride | United States | 150MG BASE, 300MG BASE, 75MG BASE | tablet | Marketed | Boehringer Ingelheim |
| Ranitidine Hydrochloride | United States | 15MG BASE/ML | syrup | Not marketed | Wockhardt |
| Ranitidine Hydrochloride | United States | 25MG BASE/ML | injectable | Not marketed | Bedford |
| Ran-Ranitidine | Canada | 150 MG | Tablet | Not marketed | Ranbaxy Pharmaceuticals Canada INC. |
| Ran-Ranitidine | Canada | 300 MG | Tablet | Not marketed | Ranbaxy Pharmaceuticals Canada INC. |
| Mar-Ranitidine | Canada | 300 MG | Tablet | Marketed | Marcan Pharmaceuticals INC |
| Mar-Ranitidine | Canada | 150 MG | Tablet | Marketed | Marcan Pharmaceuticals INC |
| Mint-Ranitidine | Canada | 150 MG | Tablet | Marketed | Mint Pharmaceuticals INC |
| Mint-Ranitidine | Canada | 300 MG | Tablet | Marketed | Mint Pharmaceuticals INC |
| Apo-Ranitidine | Canada | 75 MG / 5 ML | Solution | Not marketed | Apotex INC |
| Jamp-Ranitidine | Canada | 150 MG | Tablet | Not marketed | Jamp Pharma Corporation |
| Jamp-Ranitidine | Canada | 300 MG | Tablet | Not marketed | Jamp Pharma Corporation |
| APO-RANITIDINE TABLET 150 mg | Singapore | 150 mg | tablet, film coated | Authorised | Pharmaforte Singapore Pte LTD |
| Apo-Ranitidine Tablet 150MG | Canada | 150 MG | Tablet | Not marketed | Apotex INC |
| Apo-Ranitidine Tablet 300MG | Canada | 300 MG | Tablet | Not marketed | Apotex INC |
| Apo-Ranitidine 150MG F.C.Tab. | Saudi Arabia | Authorised | Apotex | ||
| Apo-Ranitidine 300MG F.C.Tab. | Saudi Arabia | Authorised | Apotex | ||
| Zantac in Plastic Container | United States | 1MG BASE/ML, 50MG BASE/100ML | injectable | Not marketed | Pai Holdings Pharm |
| Iquego - Ranitidina | Brazil | Authorised | Indústria Química do Estado de Goiás S/A - Iquego | ||
| Zantac | United States | 25MG BASE/ML | injectable | Not marketed | Pai Holdings Pharm |
| Zantac | United States | 15MG BASE/ML | syrup | Not marketed | Glaxo GRP LTD |
| Zantac 150 | United States | 150MG BASE | capsule | Not marketed | Glaxosmithkline |